Ertuğrul Güçlü
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 9
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 13
- SARS-CoV-2 and COVID-19 Research 4
- Hepatology top 10%
- Hepatitis C virus research 9
-
- Hepatitis B Virus Studies 10
- Liver Disease Diagnosis and Treatment 6
-
- Long-Term Effects of COVID-19 6
-
- COVID-19 and healthcare impacts 4
- Co-authors
- Oğuz KarabayAziz ÖğütlüSelçuk YaylacıMehmet KöroğluHavva KocayiğitMustafa ZenginHayriye Genç Bilgiçliİlhami Gülçın
- Journals
- SHILAP Revista de lepidopterología (5 papers)Annals of the Rheumatic Diseases (1 paper)International Journal of Infectious Diseases (1 paper)
- Partner nations
- TürkiyeUnited KingdomUnited States
In The Last Decade
Ertuğrul Güçlü
55 papers receiving 667 citations
Peers
Comparison fields: 5 of 108
- Applied Microbiology and Biotechnology 65
- Molecular Medicine 74
- Infectious Diseases 237
- Hepatology 60
- Critical Care and Intensive Care Medicine 33
Countries citing papers authored by Ertuğrul Güçlü
This map shows the geographic impact of Ertuğrul Güçlü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ertuğrul Güçlü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ertuğrul Güçlü more than expected).
Fields of papers citing papers by Ertuğrul Güçlü
This network shows the impact of papers produced by Ertuğrul Güçlü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ertuğrul Güçlü. The network helps show where Ertuğrul Güçlü may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ertuğrul Güçlü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 23 | |
| 9 | 2020 | 5 | |
| 10 | 2020 | 21 | |
| 11 | 2020 | 16 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 0 | |
| 14 | 2019 | 1 | |
| 15 | 2019 | 1 | |
| 16 | 2018 | 122 | |
| 17 | 2018 | 0 | |
| 18 | Serum prolidase activity as an indicator of liver fibrosis in chronic hepatitis B infection | 2017 | 1 |
| 19 | Efficacy of Education and Dissemination of Alcohol-Based Hand Antiseptics in the Hospital in Improving Hand Hygiene Compliance | 2012 | 3 |
| 20 | 2012 | 1 |
About Ertuğrul Güçlü
Ertuğrul Güçlü is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 64 papers that have together received 688 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (13 papers), Hepatitis B Virus Studies (10 papers), Antibiotic Resistance in Bacteria (9 papers), Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (6 papers), Long-Term Effects of COVID-19 (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and COVID-19 and healthcare impacts (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (65 citations), Molecular Medicine (74 citations) and Infectious Diseases (237 citations). Ertuğrul Güçlü has collaborated with scholars based in Türkiye, United Kingdom and United States. Frequent co-authors include Oğuz Karabay, Aziz Öğütlü, Selçuk Yaylacı, Mehmet Köroğlu, Havva Kocayiğit, Mustafa Zengin, Hayriye Genç Bilgiçli, İlhami Gülçın, Parham Taslımı and Yusuf Yürümez. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.